AFYA SRL
The score of AFYA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets -54 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AFYA's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
AFYA's financial analysis
- Solvency-19.5%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AFYA
AFYA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0790.726.677
- VAT number
- BE0790726677
- Peppol
- Registered · 0208:0790726677 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Sep 2022
- Registered office
- 4460 Grâce-Hollogne
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
AFYA (SRL) has been based in Grâce-Hollogne since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 91 € and equity of −1,684 €; its revenue is not published. Its solvency stands at -19.5%, below the median of its sector (40.1%).
Companies similar to AFYA
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Pharmawings Retail sale of pharmaceutical products Pittem · balance sheet 7,404 €
- Camille Loward Retail sale of pharmaceutical products Beersel · balance sheet 18,302 €
- Grace Partner Retail sale of pharmaceutical products Quaregnon · balance sheet 19,066 €
- LEJV Retail sale of pharmaceutical products Bertrix · balance sheet 34,528 €
- DEL Pharma Retail sale of pharmaceutical products Mons · balance sheet 36,943 €
- Meli Pharm Retail sale of pharmaceutical products Schaerbeek · balance sheet 224,525 €
- Siga Pharm Retail sale of pharmaceutical products Uccle · balance sheet 46,193 €
Frequently asked questions about AFYA
What is the revenue of AFYA?
AFYA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AFYA?
In Belgium, the VAT number is the company number prefixed with BE: BE0790726677 for AFYA, if the company is VAT-registered. Its company number (CBE) is 0790.726.677.
Where is the registered office of AFYA?
According to the CBE register, the registered office of AFYA is in 4460 Grâce-Hollogne.
What is the equity of AFYA?
At the close of the 2025 financial year, the equity of AFYA amounts to -1,684 €, a solvency of -19.5% of total assets.
Who manages AFYA?
The register lists 1 active mandates at AFYA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AFYA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →